Target intelligence / Profile preview

Catenin (cadherin-associated protein), alpha 1, 102kDa pseudogene (CTNNA1 pseudogene)

Target
CTNNA1 pseudogene
Molecular classification
Other (Pseudogene)
01

Overview

Catenin (cadherin-associated protein), alpha 1, 102kDa pseudogene (ENSG00000270422) is classified as a pseudogene related to the CTNNA1 locus[1][3]. Unlike the functional CTNNA1 gene, which encodes the alpha-catenin protein involved in cell adhesion, signal transduction, and tumor suppression[5], this pseudogene does not produce functional protein. Pseudogenes such as CTNNA1 pseudogene can have regulatory roles through non-coding RNAs that modulate their parental gene or other pathways, notably via competitive endogenous RNA effects[2][4]. Research suggests some CTNNA1 pseudogenes may participate in cancer-associated ceRNA networks and have possible biomarker characteristics; however, they are not considered direct therapeutic targets, and confusion with the protein-coding CTNNA1 gene should be explicitly avoided[4]. Technical challenges include difficulty in experimental discrimination between the pseudogene and functional gene due to sequence similarity, which can lead to off-target effects in gene silencing or editing studies[2][4]. If your intent is to research a molecular target for drug development or therapeutic intervention, you should refer to CTNNA1 (Catenin alpha-1, the protein-coding gene) rather than this pseudogene[1][3][5].

Other names
CTNNAP1Catenin alpha-1 pseudogeneCadherin-associated protein alpha 1 pseudogene
02

Biological functions

Regulation of gene expression (via ceRNA effects)Possible involvement in competitive endogenous RNA (ceRNA) networks affecting CTNNA1 functionOther (Pseudogenes may produce non-coding RNA that regulates the parental gene indirectly)
03

Disease associations

Cancer (via pseudogene-associated regulatory networks and ceRNA effects)Other (Pseudogenes can be involved in disease via gene expression regulation but are not primary disease-causing or drug targets)
04

Safety considerations

Off-target effects in gene editing or knockdown due to sequence similarity with CTNNA1 protein-coding geneTechnical challenges in distinguishing pseudogene from functional gene for RNA/protein-based assays
05

Biomarkers

Possible use as a biomarker in ceRNA/prognostic expression networks in cancer, but not commonly used clinically

Beyond the preview

Go deeper on Catenin (cadherin-associated protein), alpha 1, 102kDa pseudogene (CTNNA1 pseudogene).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catenin (cadherin-associated protein), alpha 1, 102kDa pseudogene (CTNNA1 pseudogene).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call